A Novel Inhibitor of Cyclin-Cdk Activity Detected in Transforming Growth Factor β-Arrested Epithelial Cells

REFERENCES

• Adlakha, R. C., C. G. Sahasrabuddhe, D. A. Wright, and P. N. Rao. 1983. Evidence for the presence of inhibitors of mitotic factors during the Gl period in mammalian cells. J. Cell Biol. 97: 1707–1713.
   Google Scholar
• Arteaga, C. L., A. K. Tandon, D. D. Van Hoff, and C. K. Osborne. 1988. Transforming growth factor β; potential autocrine growth control inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res. 48: 3898–3904.
   PubMed Web of Science ®Google Scholar
• Bailly, E., and S. Reed. Unpublished data.
   Google Scholar
• Baldin, V., J. Lukas, M. J. Marcote, M. Pagano, and G. Draetta. 1993. Cyclin Dl is a nuclear protein required for cell cycle progression in G1 Genes Dev. 7: 812–821.
   PubMed Web of Science ®Google Scholar
• Beach, D., B. Durkacz, and P. Nurse. 1982. Functionally homologous cell cycle control genes in fission yeast and budding yeast. Nature (London) 300: 706–709.
   PubMed Web of Science ®Google Scholar
• Booher, R., and D. Beach. 1986. Site-specific mutagenesis of cdc2+, a cell cycle control gene of the fission yeast Schizosaccha-romyces pombe. Mol. Cell. Biol. 6: 3523–3530.
   Google Scholar
• Bookstein, R., and W.-H. Lee. 1991. Molecular genetics of the retinoblastoma suppressor gene. Crit. Rev. Oncog. 2: 211–227.
   PubMedGoogle Scholar
• Bucking-Throm, E., W. Duntze, L. H. Hartwell, and T. R. Manney. 1973. Reversible arrest of haploid yeast cells at the initiation of DNA synthesis by a diffusible sex factor. Exp. Cell Res. 76: 99–110.
   PubMedGoogle Scholar
• Cantley, L. C., L. Josephson, R. Warner, M. Yanagisawa, C. Lechene, and G. Guiodotti. 1977. Vanadate is a potent (Na-K)-ATPase inhibitor found in ATP derived from muscle. J. Biol. Chem. 252: 7421–7423.
   PubMed Web of Science ®Google Scholar
• Chang, F., and I. Herskowitz. 1990. Identification of a gene necessary for cell cycle arrest by a negative growth factor of yeast: FAR1 is an inhibitor of a Gl cyclin, CLN2. Cell 63: 999–1011.
   PubMedGoogle Scholar
• Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294–5299.
   PubMed Web of Science ®Google Scholar
• Cohen, P. 1989. The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58: 453–508.
   PubMed Web of Science ®Google Scholar
• Cross, F. R. 1988. DAF1, a mutant gene affecting size control, pheromone arrest, and cell cycle kinetics of Saccharomyces cerevisiae. Mol. Cell. Biol. 8: 4675–4684.
   Google Scholar
• DeBondt, H. L., J. Rosenblatt, J. Jancarik, H. D. Jones, D. O. Morgan, and S.-H. Kim. 1993. Crystal structure of cyclin-depen-dent kinase 2. Nature (London) 363: 595–602.
   PubMed Web of Science ®Google Scholar
• Doree, M. 1990. Control of M-phase by maturation-promoting factor. Curr. Opin. Cell Biol. 2: 269–273.
   PubMed Web of Science ®Google Scholar
• Draetta, G., and D. Beach. 1988. Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell 54: 17–26.
   PubMed Web of Science ®Google Scholar
• Draetta, G., L. Brizuela, J. Potashkin, and D. Beach. 1987. Identification of p34 and pl3, human homologs of the cell cycle regulators of fission yeast encoded by cdc2+ and suc1+. Cell 50: 319–325.
   PubMedGoogle Scholar
• Ducommun, B., P. Brambilla, M.-A. Felix, B. R. FranzaJr., E. Karsenti, and G. Draetta. 1991. cdc2 phosphorylation is required for its interaction with cyclin. EMBO J. 10: 3311–3319.
   PubMed Web of Science ®Google Scholar
• Dulic, V., W. K. Kaufman, S. J. Wilson, T. D. Tosty, E. Lees, J. W. Harper, S. J. El ledge, and S. I. Reed. 1994. p53 dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced Gl arrest. Cell 76: 1013–1023.
   PubMed Web of Science ®Google Scholar
• Dulic, V., E. Lees, and S. I. Reed. 1992. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257: 1958–1961.
   PubMed Web of Science ®Google Scholar
• Dunphy, W. G., L. Brizuela, D. Beach, and J. Newport. 1988. The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis. Cell 54: 423–431.
   PubMed Web of Science ®Google Scholar
• El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825.
   PubMed Web of Science ®Google Scholar
• Elledge, S. J., R. Richman, F. L. Hall, R. T. Williams, N. Lodgson, and J. W. Harper. 1992. CDK2 encodes a 33-kDa cyclin Associated protein kinase and is expressed before CDC2 in the cell cycle. Proc. Natl. Acad. Sci. USA 89: 2907–2911.
   PubMedGoogle Scholar
• Elledge, S. J., and M. R. Spottswood. 1991. A new human p34 protein kinase, CDK2, identified by complementation of a cdc28 mutation in Saccharomyces cerevisiae, is a homolog of Xenopus Egl. EMBO J. 10: 2653–2659.
   PubMed Web of Science ®Google Scholar
• Ewen, M. E., H. K. Sluss, L. L. Whitehouse, and D. M. Livingston. 1993. TGF-p inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 74: 1009–1020.
   PubMed Web of Science ®Google Scholar
• Fang, F., and J. Newport. 1991. Evidence that the Gl-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes. Cell 66: 731–742.
   PubMed Web of Science ®Google Scholar
• Filmus, J., and R. Kerbel. 1993. Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-β during tumor progression. Curr. Opin. Oncol. 5: 123–129.
   PubMedGoogle Scholar
• Gautier, J., C. Norbury, M. Lohka, P. Nurse, and J. Mailer. 1988. Purified maturation-promoting factor contains the product of a Xenopus homolog of the fission yeast cell cycle control gene cdc2+. Cell 54: 433–439.
   PubMed Web of Science ®Google Scholar
• Geng, Y., and R. A. Weinberg. 1993. Transforming growth factor β effects on expression of Gl cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. USA 90: 10315–10319.
   PubMed Web of Science ®Google Scholar
• Gerwin, B. I., E. Spillare, K. Forrester, T. A. Lehman, J. Kispert, J. A. Welsh, A. M. Pfeifer, J. F. Lechner, S. J. Baker, B. Vogelstein, and C. C. Harris. 1992. Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce responsiveness to a negative growth factor, transforming growth factor β1. Proc. Natl. Acad. Sci. USA 89: 2759–2763.
   PubMed Web of Science ®Google Scholar
• Ghiara, J. B., H. E. Richardson, K. Sugimoto, M. Henze, D. J. Lew, C. Wittenberg, and S. I. Reed. 1991. A cyclin B homolog in S. cerevisiae: chronic activation of the Cdc28 protein kinase by cyclin prevents exit from mitosis. Cell 65: 163–174.
   PubMed Web of Science ®Google Scholar
• Gibbons, I. R., M. P. Cosson, J. A. Evans, B. H. Gibbons, B. Houck, K. H. Martinson, W. H. Sale, and W. J. Y. Tang. 1978. Potent inhibitor of dynein adenosinetriphosphatase and of the mobility of cilia and sperm flagella by vanadate. Proc. Natl. Acad. Sci. USA 75: 2220–2224.
   PubMedGoogle Scholar
• Giordano, A., P. Whyte, E. Harlow, B. R. FranzaJr., D. Beach, and G. Draetta. 1989. A 60 kd cdc2-associated polypeptide complexes with the El A proteins in adenovirus-infected cells. Cell 58: 981–990.
   PubMed Web of Science ®Google Scholar
• Girard, F., U. Strausfeld, A. Fernandez, and N. Lamb. 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67: 1169–1179.
   PubMed Web of Science ®Google Scholar
• Gould, K. L., S. Moreno, D. J. Owen, S. Sazer, and P. Nurse. 1991. Phosphorylation at Thrl67 is required for Schizosaccharo-myces pombe p34cdc2 function. EMBO J. 10: 3297–3309.
   PubMed Web of Science ®Google Scholar
• Gu, Y., J. Rosenblatt, and D. O. Morgan. 1992. Cell cycle regulation of CDK2 activity by phosphorylation of Thrl60 and Tyrl5. EMBO J. 11: 3995–4005.
   PubMed Web of Science ®Google Scholar
• Gu, Y., C. W. Turck, and D. O. Morgan. 1993. Inhibition of Cdk2 activity in vivo by an associated 20K regulatory subunit. Nature (London) 366: 707–710.
   PubMed Web of Science ®Google Scholar
• Gyuris, J., E. Golemis, H. Chertkov, and R. Brent. 1993. Cdil, a human Gl and S phase protein phosphatase that associates with Cdk2. Cell 75: 791–803.
   PubMed Web of Science ®Google Scholar
• Hadwiger, J. A., C. Wittenberg, M. A. de Barros Lopes, H. E. Richardson, and S. I. Reed. 1989. A family of cyclin homologs that control Gl phase in yeast. Proc. Natl. Acad. Sci. USA 86: 6255–6259.
   PubMedGoogle Scholar
• Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cipl is a potent inhibitor of Gl cyclin-dependent kinases. Cell 75: 805–816.
   PubMed Web of Science ®Google Scholar
• Hartwell, L., and M. Unger. 1977. Unequal division in Saccharomyces cerevisiae and its implications for the control of cell division. J. Cell Biol. 75: 422–435.
   PubMed Web of Science ®Google Scholar
• Hartwell, L. H., J. Culotti, J. R. Pringle, and B. J. Reid. 1974. Genetic control of the cell division cycle in yeast. Science 183: 46–51.
   PubMed Web of Science ®Google Scholar
• Hengst, L., V. Dulic, J. Slingerland, E. Lees, and S. I. Reed. A cell cycle regulated inhibitor of cyclin dependent kinases. Proc. Natl. Acad. Sci. USA, in press.
   Google Scholar
• Hollstein, M., D. Sidransky, B. Vogelstein, and C. C. Harris. 1991. p53 mutations in human cancers. Science 253: 49–53.
   PubMed Web of Science ®Google Scholar
• Hosobuchi, M., and M. Stampfer. 1989. Effects of the transforming growth factor p on growth of human mammary epithelial cells in culture. In Vitro Cell Dev. Biol. 25: 705–713.
   PubMedGoogle Scholar
• Howe, P. H., G. Draetta, and E. B. Leof. 1991. Transforming growth factor pi inhibition of p34cdc2 phosphorylation and histone HI kinase activity is associated with Gl/S-phase growth arrest. Mol. Cell. Biol. 11: 1185–1194.
   PubMed Web of Science ®Google Scholar
• Jiang, W., S. Kahan, N. Tomita, Y. Zhang, S. Lu, and B. Weinstein. 1992. Amplification and expression of the human cyclin D gene in esophageal cancers. Cancer Res. 52: 2980–2983.
   PubMed Web of Science ®Google Scholar
• Kato, J.-Y., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7: 331–342.
   PubMed Web of Science ®Google Scholar
• Keyomarsi, K., and A. B. Pardee. 1993. Redundant cyclin over-expression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA 90: 1112–1116.
   PubMed Web of Science ®Google Scholar
• Kimchi, A., X.-F. Wang, R. A. Weinberg, S. Cheifetz, and J. Massague. 1988. Absence of TGF-p receptors and growth inhibitory responses in retinoblastoma cells. Science 240: 196–198.
   PubMed Web of Science ®Google Scholar
• Klarlund, J. K. 1985. Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins. Cell 41: 707–717.
   PubMed Web of Science ®Google Scholar
• Koff, A., F. Cross, A. Fisher, J. Schumacher, K. Leguellec, M. Philippe, and J. M. Roberts. 1991. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66: 1217–1228.
   PubMed Web of Science ®Google Scholar
• Koff, A., A. Giordano, D. Desai, K. Yamashita, J. W. Harper, S. Elledge, T. Nishimoto, D. O. Morgan, R. B. Franza, and J. M. Roberts. 1992. Formation and activation of a cyclin E-cdk2 complex during the Gl phase of the human cell cycle. Science 257: 1689–1694.
   PubMed Web of Science ®Google Scholar
• Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massague. 1993. Negative regulation of Gl in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-p. Science 260: 536–539.
   PubMed Web of Science ®Google Scholar
• Kumar, A., T. Rogers, A. Maizel, and S. Sharma. 1991. Loss of transforming growth factor β1 receptors and its effects on the growth of EBV-transformed human B cells. J. Immunol. 147: 998–1006.
   PubMed Web of Science ®Google Scholar
• Labbe, J. C., A. Picard, G. Peaucellier, J. C. Cavadore, P. Nurse, and M. Doree. 1989. Purification of MPF from starfish: identification as the HI histone kinase p34cdc2 and a possible mechanism for its periodic activation. Cell 57: 253–263.
   PubMed Web of Science ®Google Scholar
• Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227: 680–685.
   PubMed Web of Science ®Google Scholar
• Laiho, M., J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massague. 1990. Growth inhibition by TGF-β1 linked to suppression of retinoblastoma protein phosphorylation. Cell 62: 175–185.
   PubMed Web of Science ®Google Scholar
• Laiho, M., F. M. B. Weis, and J. Massague. 1990. Concomitant loss of transforming growth factor-β receptor types I and II in TGF-β resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem. 265: 18518–18524.
   PubMed Web of Science ®Google Scholar
• Lammie, G. A., V. Fantl, R. Smith, E. Schuuring, S. Brokes, R. Dickson, A. Arnold, and G. Peters. 1991. D11S287, a putative oncogene on chromosome llql3, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6: 439–444.
   PubMedGoogle Scholar
• Langhan, T. A., J. Gauthier, M. Lohka, R. Hollingsworth, S. Moreno, P. Nurse, J. L. Mailer, and R. A. Sclafani. 1989. Mammalian growth-associated HI kinase: a homolog of cdc2+/ CDC28 protein kinases controlling mitotic entry in yeast and frogs. Mol. Cell. Biol. 9: 3860–3868.
   Google Scholar
• Lee, M. G., and P. Nurse. 1987. Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2 from humans. Nature (London) 292: 558–560.
   Google Scholar
• Lees, E., B. Faha, V. Dulic, S. I. Reed, and E. Harlow. 1992. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with pl07 and E2F in a temporally distinct manner. Genes Dev. 6: 1874–1885.
   PubMed Web of Science ®Google Scholar
• Leopold, P., and P. O'Farrell. 1991. An evolutionarily conserved cyclin homolog from drosophila rescues yeast deficient in Gl cyclins. Cell 66: 1207–1216.
   PubMed Web of Science ®Google Scholar
• Levine, A. J., J. Momand, and C. A. Finlay. 1991. The p53 tumour suppressor gene. Nature (London) 351: 453–456.
   PubMed Web of Science ®Google Scholar
• Lew, D. J., V. Dulic, and S. I. Reed. 1991. Isolation of three novel human cyclins by rescue of Gl cyclin (Cln) function in yeast. Cell 66: 1197–1206.
   PubMed Web of Science ®Google Scholar
• Massague, J. 1990. The transforming growth factor-p family. Annu. Rev. Cell Biol. 6: 597–641.
   PubMedGoogle Scholar
• Massague, J., S. Cheifetz, M. Laiho, D. A. Ralph, F. M. B. Weis, and A. Zentella. 1992. Transforming growth factor-p. Cancer Surv. 12: 81–103.
   PubMedGoogle Scholar
• Masui, T., L. M. Wakefield, J. F. Lechner, M. A. LaVeck, M. B. Sporn, and C. C. Harris. 1986. Type β transforming growth factor is the primary differentiation inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA 83: 2438–2442.
   PubMed Web of Science ®Google Scholar
• Matsushime, H., M. E. Ewen, D. K. Strom, J. Kato, S. K. Hanks, M. F. Roussel, and C. J. Sherr. 1992. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type Gl cyclins. Cell 71: 323–334.
   PubMed Web of Science ®Google Scholar
• Matsushime, H., M. F. Roussel, R. A. Ashmun, and C. J. Sherr. 1991. Colony-stimulating factor 1 regulates novel cyclins during the Gl phase of the cell cycle. Cell 65: 701–713.
   PubMed Web of Science ®Google Scholar
• McMahon, J. B., W. L. Richards, C. C. del Campo, M.-K. Song, and S. S. Thorgiersson. 1986. Differential effects of transforming growth factor-β on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res. 46: 4665–4671.
   PubMed Web of Science ®Google Scholar
• Mendenhall, M. D. 1993. An inhibitor of p34CDC28 protein kinase activity from Saccharomyces cerevisiae. Science 259: 216–219.
   PubMed Web of Science ®Google Scholar
• Mendenhall, M. D., C. A. Jones, and S. I. Reed. 1987. Dual regulation of the yeast Cdc28-p40 protein kinase complex: cell cycle, pheromone, and nutrient limitation effects. Cell 50: 927–935.
   PubMedGoogle Scholar
• Meyerson, M., G. H. Enders, C. Wu, L. Su, C. Gorka, C. Nelson, E. Harlow, and L. Tsai. 1992. A family of human cdc2-related protein kinases. EMBO J. 11: 2909–2917.
   PubMed Web of Science ®Google Scholar
• Motokura, T., T. Bloom, H. G. Kim, H. Juppner, J. V. Ruderman, H. M. Kronenberg, and A. Arnold. 1991. A novel cyclin encoded by a bcl 1-linked candidate oncogene. Nature (London) 350: 512–515.
   PubMed Web of Science ®Google Scholar
• Munger, K., J. A. Peitenpol, M. R. Pittelkow, J. T. Holt, and H. L. Moses. 1992. Transforming growth factor pi regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes. Cell Growth Differ. 3: 291–298.
   PubMedGoogle Scholar
• Nash, R., G. Tokiwa, S. Anand, K. Erickson, and A. B. Futcher. 1988. The WHI1+ gene of S. cerevisiae tethers cell division to cell size and is a cyclin homolog. EMBO J. 7: 4335–4346.
   PubMed Web of Science ®Google Scholar
• Ninomiya-Tsuji, J., S. Nomoto, H. Yasuda, and S. I. Reed. 1991. Cloning of a human cDNA encoding a CDC2-related kinase by complementation of a budding yeast cdc28 mutation. Proc. Natl. Acad. Sci. USA 88: 9006–9010.
   PubMed Web of Science ®Google Scholar
• Norbury, C., J. Blow, and P. Nurse. 1991. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J. 10: 3321–3329.
   PubMed Web of Science ®Google Scholar
• Nurse, P. 1975. Genetic control of cell size at cell division in yeast. Nature (London) 256: 547–551.
   PubMed Web of Science ®Google Scholar
• Nurse, P., and Y. Bissett. 1981. Gene required in Gl for commitment to the cell cycle and in G2 for control of mitosis in fission yeast. Nature (London) 292: 558–560.
   PubMed Web of Science ®Google Scholar
• Ohtsubo, M., and J. M. Roberts. 1993. Cyclin-dependent regulation of Gx in mammalian cells. Science 259: 1908–1912.
   PubMed Web of Science ®Google Scholar
• Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11: 961–971.
   PubMed Web of Science ®Google Scholar
• Pardee, A. B. 1989. Gl events and regulation of cell proliferation. Science 246: 603–608.
   PubMed Web of Science ®Google Scholar
• Pardee, A. B. 1974. A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. USA 71: 1286–1290.
   PubMed Web of Science ®Google Scholar
• Paris, J., R. Le Guellec, A. Couturier, K. Le Guellec, F. Omilli, J. Camonis, S. MacNiell, and M. Philippe. 1991. Cloning by differential screening of a Xenopus cDNA coding for a protein highly homologous to cdc2. Proc. Natl. Acad. Sci. USA 88: 1039–1043.
   PubMedGoogle Scholar
• Peter, M., A. Gartner, J. Horecka, G. Ammerer, and I. Herskow-itz. 1993. FAR1 links the signal transduction pathway to the cell cycle machinery in yeast. Cell 73: 747–760.
   PubMedGoogle Scholar
• Piggott, J. R., R. Rai, and B. L. A. Carter. 1982. A bifunctional gene product involved in two phases of the yeast cell cycle. Nature (London) 298: 391–393.
   PubMedGoogle Scholar
• Pines, J., and T. Hunter. 1989. Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58: 833–846.
   PubMed Web of Science ®Google Scholar
• Pines, J., and T. Hunter. 1990. Human cyclin A is adenovirus ElA-associated protein p60 and behaves differently from cyclin B. Nature (London) 346: 760–763.
   PubMed Web of Science ®Google Scholar
• Polyak, K., J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff. 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8: 9–22.
   PubMed Web of Science ®Google Scholar
• Quelle, D. E., R. A. Ashmun, S. A. Shurtleff, J. Kato, D. Bar-Sagi, M. F. Roussel, and C. J. Sherr. 1993. Overexpression of mouse D-type cyclins accelerates Gl phase in rodent fibroblasts. Genes Dev. 7: 1559–1571.
   PubMed Web of Science ®Google Scholar
• Reed, S. I. 1991. Gl-specific cyclins: in search of an S-phase-promoting factor. Trends Genet. 7: 95–99.
   PubMed Web of Science ®Google Scholar
• Reed, S. I., J. A. Hadwiger, and A. T. Lorincz. 1985. Protein kinase activity associated with the product of the yeast cell division cycle gene CDC28. Proc. Natl. Acad. Sci. USA 82: 4055–4059.
   PubMed Web of Science ®Google Scholar
• Reed, S. L., and C. Wittenberg. 1990. A mitotic function for the Cdc28 protein kinase of S. cerevisiae. Proc. Natl. Acad. Sci. USA 87: 5697–5701.
   PubMedGoogle Scholar
• Resnitzky, D., M. Gossen, H. Bujard, and S. Reed. 1994. Acceleration of the G,/S phase transition by expression of cyclins Dl and E with an inducible system. Mol. Cell. Biol. 14: 1669–1679.
   PubMed Web of Science ®Google Scholar
• Riabowol, K., G. Draetta, L. Brizuela, D. Vandre, and D. Beach. 1989. The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell 57: 393–401.
   PubMed Web of Science ®Google Scholar
• Richardson, H. E., C. Wittenberg, F. R. Cross, and S. I. Reed. 1989. An essential Gl function for cyclin-like proteins in yeast. Cell 59: 1127–1133.
   PubMed Web of Science ®Google Scholar
• Roberts, A. B., M. A. Anzano, L. C. Lamb, J. M. Smith, and M. B. Sporn. 1981. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc. Natl. Acad. Sci. USA 78: 5339–5343.
   PubMed Web of Science ®Google Scholar
• Rosenberg, C. L., E. Wong, E. M. Petty, A. E. Bale, Y. Tsujimoto, N. L. Harris, and A. Arnold. 1991. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc. Natl. Acad. Sci. USA 88: 9638–9642.
   PubMed Web of Science ®Google Scholar
• Rosenblatt, J., H. De Bondt, J. Jancarik, D. O. Morgan, and S. H. Kim. 1993. Purification and crystallization of human cyclin-dependent kinase 2. J. Mol. Biol. 230: 1317–1319.
   PubMedGoogle Scholar
• Rosenblatt, J., Y. Gu, and D. O. Morgan. 1992. Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc. Natl. Acad. Sci. USA 89: 2824–2828.
   PubMed Web of Science ®Google Scholar
• Shipley, G. D., M. R. Pittelkow, J. J. Wille, R. E. Scott, and H. L. Moses. 1986. Reversible inhibition of normal human prokerati-nocyte proliferation by type p transforming growth factor-growth inhibitor in serum-free medium. Cancer Res. 46: 2068–2071.
   PubMed Web of Science ®Google Scholar
• Solomon, M., M. Glotzer, T. Lee, M. Philippe, and M. Kirschner. 1990. Cyclin activation of p34cdc2. Cell 63: 1013–1024.
   PubMed Web of Science ®Google Scholar
• Solomon, M., T. Lee, and M. Kirschner. 1992. Role of phosphorylation in p34cdc2 activation: identification of an activating kinase. Mol. Biol. Cell. 3: 13–27.
   PubMed Web of Science ®Google Scholar
• Stampfer, M. 1985. Isolation and growth of human mammary epithelial cells. J. Tissue Cult. Methods 9: 107–115.
   Google Scholar
• Stampfer, M. R., C.-H. Pan, J. Hosoda, J. Bartholomew, J. Mendelsohn, and P. Yaswen. 1993. Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous re-entry into the cell cycle. Exp. Cell Res. 208: 175–188.
   PubMedGoogle Scholar
• Surana, U., H. Robitsch, C. Price, T. Shuster, I. Fitch, A. B. Futcher, and K. Nasmyth. 1991. The role of CDC28 and cyclins during mitosis in the budding yeast S. cerevisiae. Cell 65: 145–161.
   PubMed Web of Science ®Google Scholar
• Takehara, K., E. C. LeRoy, and G. R. Grotendorst. 1987. TGF-β inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell 49: 415–422.
   PubMed Web of Science ®Google Scholar
• Th'ng, J. P. H., P. S. Wright, J. Hamaguchi, M. G. Lee, C. J. Norbury, P. Nurse, and E. M. Bradbury. 1990. The FT210 cell line is a mouse G2 phase mutant with a temperature-sensitive CDC2 gene product. Cell 63: 313–324.
   PubMed Web of Science ®Google Scholar
• Tonks, N. K., C. D. Diltz, and E. H. Fischer. 1988. Characterization of the major protein-tyrosine-phosphatase of human placenta. J. Biol. Chem. 263: 6731–6737.
   PubMed Web of Science ®Google Scholar
• Tsai, L.-H., E. Harlow, and M. Meyerson. 1991. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus ElA-associated p33 kinase. Nature (London) 353: 174–177.
   PubMed Web of Science ®Google Scholar
• Tsai, L.-H., E. Lees, B. Faha, E. Harlow, and K. Riabowol. 1993. The cdk2 kinase is required for the Gl-to-S transition in mammalian cells. Oncogene 8: 1593–1602.
   PubMed Web of Science ®Google Scholar
• Wittenberg, C., and S. I. Reed. 1989. Conservation of function and regulation within the Cdc28/cdc2 protein kinase family: characterization of the human Cdc2Hs protein kinase in Saccharomyces cerevisiae. Mol. Cell Biol. 9: 4064–4068.
   Google Scholar
• Wittenberg, C., K. Sugimoto, and S. I. Reed. 1990. Gl-specific cyclins of Saccharomyces cerevisiae: cell cycle periodicity, regulation by mating pheromone and association with the p34CDC28 protein kinase. Cell 62: 225–237.
   PubMed Web of Science ®Google Scholar
• Wyllie, F. S., T. Dawson, J. A. Bond, P. Gortetski, S. Game, S. Prime, and D. Wynford-Thomas. 1991. Correlated abnormalities of transforming growth factor-β1 response and p53 expression in thyroid epithelial cell transformation. Mol. Cell. Endocrinol. 76: 13–21.
   PubMedGoogle Scholar
• Xiong, Y., T. Connolly, B. Futcher, and D. Beach. 1991. Human D-type cyclin. Cell 65: 691–699.
   PubMed Web of Science ®Google Scholar
• Xiong, Y., G. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature (London) 366: 701–704.
   PubMed Web of Science ®Google Scholar
• Yamashita, M., S. Fukada, M. Yoshikuni, P. Bulet, T. Hirai, A. Yamaguchi, Y. H. Lou, Z. Zhao, and Y. Nagahama. 1992. Purification and characterization of maturation-promoting factor in fish. Dev. Biol. 1: 8–15.
   Google Scholar
• Yaswen, P., A. Smoll, D. M. Peehl, D. K. Trask, R. Sager, and M. R. Stampfer. 1990. Down-regulation of a calmodulin-related gene during transformation of human mammary epithelial cells. Proc. Natl. Acad. Sci. USA 87: 7360–7364.
   Google Scholar
• Zetterberg, A. 1990. Control of mammalian cell proliferation. Curr. Opin. Cell Biol. 2: 296–300.
   PubMedGoogle Scholar
• Zetterberg, A., and O. Larsson. 1985. Kinetic analysis of regulatory events in Gl leading to proliferation or quiescence of Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA 82: 5365–5369.
   PubMed Web of Science ®Google Scholar
• Zindy, F., E. Lamas, X. Chenivesse, J. Sobczak, J. Wang, D. Fresquet, B. Heglein, and C. Brechot. 1992. Cyclin A is required in S phase in normal epithelial cells. Biochem. Biophys. Res. Commun. 182: 1144–1154.
   PubMed Web of Science ®Google Scholar